Skip to main content

Equillium, Inc.

EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746466

No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Equillium, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of EQ: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3328−5
Shares7.63M7.11M−523.3K (−6.9%)
Value$54.6M$41.9M−$12.7M (−23.3%)

New holders (6)

Institutions that held Equillium, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to EQ in Q2 2021
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc218,162$1.28M0.00%
DCF Advisers, LLC77,538$457.0K0.23%
State Street Corp30,756$181.0K0.00%
Group One Trading, L.P.100$1.00K0.00%
Bank of America Corp7$00.00%
Barclays PLC15$00.00%

Sold out (11)

Institutions that held Equillium, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.